|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.82 DKK | +0.93% |
|
-1.80% | -15.73% |
| Capitalization | 3.36TCr 525.95Cr 449.74Cr 418.92Cr 389.64Cr 719.93Cr 45TCr 800.08Cr 5.02TCr 1.92TCr 21TCr 1.97TCr 1.93TCr 78TCr | P/E ratio 2025 * |
9.46x | P/E ratio 2026 * | 8.1x |
|---|---|---|---|---|---|
| Enterprise value | 4.27TCr 668.83Cr 571.91Cr 532.72Cr 495.48Cr 915.5Cr 57TCr 1.02TCr 6.38TCr 2.44TCr 27TCr 2.51TCr 2.46TCr 99TCr | EV / Sales 2025 * |
1.77x | EV / Sales 2026 * | 1.48x |
| Free-Float |
30.74% | Yield 2025 * |
3.37% | Yield 2026 * | 4.05% |
More valuation ratios
* Estimated data
More news
Last Transcript: H. Lundbeck A/S
More recommendations
More press releases
More news
| 1 day | +0.93% | ||
| 1 week | -1.80% | ||
| Current month | -4.24% | ||
| 1 month | -12.07% | ||
| 3 months | +24.36% | ||
| 6 months | -14.24% | ||
| Current year | -15.73% |
| 1 week | 33.38 |  | 36 |
| 1 month | 33.38 | | 40.14 |
| Current year | 27.2 | | 45.82 |
| 1 year | 27.2 | | 49.38 |
| 3 years | 23.3 | | 49.38 |
| 5 years | 23.3 | | 49.38 |
| 10 years | 23.3 | | 49.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charl van Zyl
CEO | Chief Executive Officer | 58 | 01/10/2023 |
Jörg Hornstein
DFI | Director of Finance/CFO | 48 | 01/09/2022 |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 66 | 25/03/2015 | |
| Director/Board Member | 65 | 25/03/2015 | |
| Director/Board Member | 59 | 20/03/2018 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0.25% | 4 M€ | +22.30% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.93% | -1.80% | -14.32% | -5.59% | 525.95Cr | ||
| -0.69% | -1.35% | +23.36% | +115.81% | 8.88TCr | ||
| -0.74% | -2.40% | +70.41% | +203.77% | 3.84TCr | ||
| +0.35% | -4.98% | - | - | 2.17TCr | ||
| +0.73% | -1.57% | +47.10% | -10.62% | 979.59Cr | ||
| +1.60% | +5.97% | +0.32% | +2.76% | 883.53Cr | ||
| +0.64% | +1.73% | -4.85% | -4.37% | 748.96Cr | ||
| -0.68% | -1.24% | +15.56% | +14.13% | 548.32Cr | ||
| -0.50% | +1.72% | +20.12% | +3.69% | 490.53Cr | ||
| +0.38% | +2.69% | +12.66% | +20.35% | 371.45Cr | ||
| Average | +0.26% | +0.58% | +18.93% | +37.77% | 1.94TCr | |
| Weighted average by Cap. | +0.00% | -0.48% | +31.05% | +105.04% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.41TCr 378.3Cr 323.49Cr 301.32Cr 280.25Cr 517.83Cr 32TCr 575.47Cr 3.61TCr 1.38TCr 15TCr 1.42TCr 1.39TCr 56TCr | 2.57TCr 402.91Cr 344.53Cr 320.92Cr 298.48Cr 551.51Cr 35TCr 612.91Cr 3.85TCr 1.47TCr 16TCr 1.51TCr 1.48TCr 59TCr |
| Net income | 368.66Cr 58Cr 49Cr 46Cr 43Cr 79Cr 4.96TCr 88Cr 551.48Cr 210.85Cr 2.32TCr 216.72Cr 212.25Cr 8.51TCr | 428.21Cr 67Cr 57Cr 53Cr 50Cr 92Cr 5.76TCr 102.1Cr 640.54Cr 244.9Cr 2.7TCr 251.72Cr 246.53Cr 9.89TCr |
| Net Debt | 911.55Cr 142.87Cr 122.17Cr 113.8Cr 105.84Cr 195.57Cr 12TCr 217.34Cr 1.36TCr 521.35Cr 5.74TCr 535.85Cr 524.8Cr 21TCr | 450.12Cr 71Cr 60Cr 56Cr 52Cr 97Cr 6.05TCr 107.32Cr 673.33Cr 257.44Cr 2.83TCr 264.6Cr 259.15Cr 10TCr |
More financial data
* Estimated data
Employees
5,700
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/25/11 | 34.82 kr | +0.93% | 5,08,992 |
| 10/25/10 | 34.50 kr | +1.47% | 6,28,385 |
| 09/25/09 | 34.00 kr | -4.17% | 9,68,719 |
| 08/25/08 | 35.48 kr | +0.40% | 2,33,349 |
| 07/25/07 | 35.34 kr | -0.34% | 3,33,705 |
Delayed Quote Nasdaq Copenhagen, July 11, 2025 at 08:50 pm IST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
34.82DKK
Average target price
47.46DKK
Spread / Average Target
+36.30%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HLUN B Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition